However, our study builds on these initial findings and not only confirms the causal role of PYCR2 in promoting tumorigenicity and the invasive mobility of colon cancer cells in vitro but also in vivo oncogenic growth by regulating MASTL/Wnt/β-catenin signaling. Here, PYCR2 is linked to colonic neoplasm.